Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 1:38 PM
Ignite Modification Date: 2025-12-25 @ 12:36 PM
NCT ID: NCT00803595
Description: None
Frequency Threshold: 1
Time Frame: 15 days
Study: NCT00803595
Study Brief: A Multinational Phase III Study of CS-8958 (MARVEL)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
CS-8958 High Dose 40 mg CS-8958 powder to be inhaled - high-dose arm None None 0 337 63 337 View
CS-8958 Low Dose 20 mg CS-8958 powder to be inhaled - low-dose arm None None 0 326 54 326 View
Oseltamivir 75 mg oseltamivir phosphate oral capsules None None 2 336 63 336 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Japan (12.0) View
Wallenberg syndrome SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Japan (12.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA Japan (12.0) View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA Japan (12.0) View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Japan (12.0) View
Alanine aminotransferase increase SYSTEMATIC_ASSESSMENT Investigations MedDRA Japan (12.0) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Japan (12.0) View
Urticaria SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA Japan (12.0) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA Japan (12.0) View
Gastroenteritis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Japan (12.0) View
Oral herpes SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Japan (12.0) View
Platelet count increased SYSTEMATIC_ASSESSMENT Investigations MedDRA Japan (12.0) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Japan (12.0) View